News from stealth biotherapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 01, 2020, 07:30 ET Stealth BioTherapeutics Reports Fiscal Year 2019 Financial Results And Recent Business Highlights

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Mar 30, 2020, 08:30 ET Stealth BioTherapeutics to Report Full Year 2019 Financial Results on Wednesday, April 1, 2020

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Feb 18, 2020, 07:00 ET Stealth BioTherapeutics Announces Positive Results From Study to Evaluate Efficacy of Elamipretide in Barth Patients Compared to Natural History Control

Stealth BioTherapeutics (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Jan 21, 2020, 07:30 ET Stealth BioTherapeutics Initiates First-in-Human Study of SBT-272

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Nov 19, 2019, 16:30 ET Stealth Biotherapeutics to Present at Jefferies 2019 London Healthcare Conference

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Nov 14, 2019, 07:00 ET Stealth BioTherapeutics Reports Third Quarter 2019 Financial Results And Recent Business Highlights

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Nov 11, 2019, 08:00 ET Stealth Biotherapeutics to Report Third Quarter 2019 Financial Results on Thursday, November 14, 2019

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Oct 17, 2019, 07:30 ET Stealth BioTherapeutics Presents Data for Elamipretide on Cardiac Function in Barth Syndrome

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Oct 07, 2019, 08:00 ET Stealth BioTherapeutics Presents Data on SBT-272 in Neurodegeneration

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Oct 01, 2019, 08:00 ET Stealth Biotherapeutics to Present at the 2019 Cantor Global Healthcare Conference

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Sep 20, 2019, 08:00 ET Stealth BioTherapeutics to Attend Upcoming Investor Conferences

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Sep 03, 2019, 16:30 ET Stealth BioTherapeutics Announces Appointment of Robert Weiskopf as Chief Financial Officer

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Aug 14, 2019, 16:20 ET Stealth BioTherapeutics Reports First Half 2019 Financial Results And Recent Business Highlights

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Jul 02, 2019, 08:00 ET Stealth BioTherapeutics to Host KOL Breakfast Symposium on the Potential of Elamipretide in Orphan Mitochondrial Disorders

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

May 30, 2019, 08:00 ET Stealth Biotherapeutics to Present at Upcoming Investor Conferences

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

May 15, 2019, 16:05 ET Stealth BioTherapeutics Reports First Quarter 2019 Financial Results And Recent Business Highlights

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

May 14, 2019, 16:15 ET Stealth BioTherapeutics to Present at UBS Global Healthcare Conference

Stealth BioTherapeutics (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Apr 30, 2019, 16:23 ET Stealth BioTherapeutics Announces Positive Results for Elamipretide in Ophthalmic Conditions

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Apr 25, 2019, 16:15 ET Stealth BioTherapeutics Completes Enrollment of Pivotal Study in Primary Mitochondrial Myopathy

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Apr 16, 2019, 18:01 ET Stealth BioTherapeutics Announces Positive Results for Elamipretide in Barth Syndrome Open-Label Extension Trial

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Apr 04, 2019, 19:35 ET Stealth BioTherapeutics Reports Fiscal Year 2018 Financial Results and Recent Business Highlights

Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of...

Apr 02, 2019, 08:00 ET Stealth BioTherapeutics to Present at H.C. Wainwright Global Life Sciences Conference

Stealth BioTherapeutics (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Mar 28, 2019, 08:06 ET Stealth BioTherapeutics Announces Dosing Of First Patient In Phase 2 Study Of Elamipretide For The Treatment Of Dry AMD

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Mar 04, 2019, 16:12 ET Stealth BioTherapeutics Announces Partial Exercise and Closing of Over-Allotment Option

Stealth BioTherapeutics (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...

Feb 14, 2019, 22:45 ET Stealth BioTherapeutics Announces Pricing of Initial Public Offering

Stealth BioTherapeutics (Stealth), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel...